LUPPI, Mario
 Distribuzione geografica
Continente #
NA - Nord America 54.983
AS - Asia 25.786
EU - Europa 23.508
SA - Sud America 3.453
AF - Africa 594
OC - Oceania 82
Continente sconosciuto - Info sul continente non disponibili 51
Totale 108.457
Nazione #
US - Stati Uniti d'America 54.021
SG - Singapore 7.127
GB - Regno Unito 7.078
CN - Cina 6.878
IT - Italia 5.210
HK - Hong Kong 3.888
VN - Vietnam 2.652
BR - Brasile 2.637
SE - Svezia 2.258
DE - Germania 1.890
FI - Finlandia 1.797
BD - Bangladesh 1.189
RU - Federazione Russa 1.110
UA - Ucraina 922
FR - Francia 911
TR - Turchia 810
KR - Corea 785
NL - Olanda 620
IN - India 562
CA - Canada 514
ID - Indonesia 437
BG - Bulgaria 405
AR - Argentina 279
MX - Messico 227
IQ - Iraq 203
JP - Giappone 203
ES - Italia 170
IE - Irlanda 157
ZA - Sudafrica 156
PL - Polonia 143
PK - Pakistan 134
EC - Ecuador 133
AE - Emirati Arabi Uniti 125
BE - Belgio 120
AT - Austria 116
CO - Colombia 108
CZ - Repubblica Ceca 105
LT - Lituania 94
MA - Marocco 87
VE - Venezuela 79
CL - Cile 78
AU - Australia 77
PH - Filippine 77
IR - Iran 70
KE - Kenya 67
UZ - Uzbekistan 67
SA - Arabia Saudita 65
MY - Malesia 62
BZ - Belize 58
TN - Tunisia 53
DZ - Algeria 52
JO - Giordania 52
PY - Paraguay 52
EG - Egitto 51
AZ - Azerbaigian 41
TW - Taiwan 41
RO - Romania 39
CH - Svizzera 38
TH - Thailandia 36
NP - Nepal 35
IL - Israele 34
EU - Europa 33
DK - Danimarca 31
PE - Perù 31
SI - Slovenia 31
CR - Costa Rica 30
JM - Giamaica 29
PT - Portogallo 29
BO - Bolivia 27
UY - Uruguay 27
OM - Oman 26
RS - Serbia 26
SK - Slovacchia (Repubblica Slovacca) 26
AL - Albania 24
QA - Qatar 24
ET - Etiopia 23
NO - Norvegia 21
DO - Repubblica Dominicana 20
GR - Grecia 20
HU - Ungheria 19
KZ - Kazakistan 19
CY - Cipro 17
BY - Bielorussia 16
LB - Libano 16
KG - Kirghizistan 15
NG - Nigeria 15
PS - Palestinian Territory 15
GT - Guatemala 14
PA - Panama 14
MK - Macedonia 13
NI - Nicaragua 13
SN - Senegal 13
BH - Bahrain 12
LV - Lettonia 12
EE - Estonia 11
HR - Croazia 11
BN - Brunei Darussalam 10
LU - Lussemburgo 10
MD - Moldavia 10
TT - Trinidad e Tobago 10
Totale 108.248
Città #
Ashburn 5.536
Fairfield 5.251
Southend 4.804
Santa Clara 4.657
Singapore 4.407
Hong Kong 3.758
Woodbridge 3.233
Houston 2.625
Chandler 2.613
Hefei 2.360
Seattle 2.005
San Jose 1.936
Ann Arbor 1.769
Wilmington 1.758
Jacksonville 1.738
Cambridge 1.667
Dearborn 1.402
Helsinki 1.373
Nyköping 1.251
London 1.223
Beijing 1.112
Los Angeles 1.044
Council Bluffs 989
New York 942
Chicago 923
Ho Chi Minh City 855
Modena 831
Seoul 741
The Dalles 708
Hanoi 602
Milan 555
San Diego 503
Buffalo 502
Princeton 431
Izmir 424
Sofia 393
Dallas 367
Lauterbourg 364
Salt Lake City 334
Eugene 319
Amsterdam 316
Munich 316
Moscow 310
Jakarta 305
Bologna 261
Shanghai 255
Rome 227
São Paulo 225
Columbus 184
Fremont 172
Boardman 167
Orem 167
Bremen 161
Da Nang 156
Des Moines 156
Tampa 156
Frankfurt am Main 153
Dublin 143
Phoenix 136
Toronto 134
Tokyo 133
Elk Grove Village 132
Redwood City 114
Atlanta 113
Montreal 112
Haiphong 110
Philadelphia 107
Brooklyn 105
Guangzhou 105
Nuremberg 104
Warsaw 103
Kent 102
Turku 97
Boston 91
Denver 88
Miami 87
Reggio Emilia 83
Utrecht 83
Chennai 81
Rio de Janeiro 81
Naples 77
Mexico City 76
Miano 76
Johannesburg 75
Las Vegas 74
Brussels 73
Falls Church 71
Baghdad 70
Stockholm 69
San Francisco 67
Lancaster 66
Redondo Beach 65
Norwalk 64
Mumbai 62
Nairobi 61
Vienna 61
Kilburn 60
Tashkent 60
Parma 59
Verona 59
Totale 75.781
Nome #
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. 1.005
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 592
HHV-6A in syncytial giant-cell hepatitis 468
Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation 466
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 442
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis 441
Kaposi's sarcoma after liver transplantation 439
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 429
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 422
Acquired haemophilia in HIV negative, HHV-8 positive multicentric Castleman's disease: a case report 411
B cells and herpesviruses: a model of lymphoproliferation 409
Lack of confirmation of an association between HTLV-I infection and myelodysplastic syndrome 408
Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: Hybrid Posters 406
Performance of tests for latent tuberculosis in different groups of immunocompromised patients 403
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 399
Helicobacter pylori infection andchronic immune thrombocytopenic purpura: long-term results of bacteriumeradication and association with bacterium virulence profiles 399
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 389
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 382
A t(11;20)(p15;q11) may identify a subset of nontherapy-related acute myelocytic leukemia 376
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 376
Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests 373
Bone marrow failure associated with human herpesvirus 8 infection after transplantation 371
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 371
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 369
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 367
Mucorales-specific T cells in patients with hematologic malignancies 363
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 363
Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors 362
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling 361
Human herpesvirus-8 DNA sequences in Human Immunodeficiency Virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity 358
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 358
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 358
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 358
Acute appendicitis in adult neutropenic patients with hematologic malignancies 356
A hematology consensus agreement on antifungal strategies for neutropenic patients with hematological malignancies and stem cell transplant recipients 355
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 355
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 355
Selective inhibition of PI3Kγ affects survival and proliferation of chronic lymphocytic leukemia B cells 355
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 354
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 354
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 352
Early versus delayed palliative/supportive care in advanced cancer: An observational study 352
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 351
PCR con primer degenerati non evidenzia sequenze virali di HHV-8 ne di una sua variante in cellule stromali midollari di pazienti affetti da gammopatie monoclonali 351
Chronic myeloid leukemia with thrombocythemic onset may be associated with different BCR/ABL variant transcripts 347
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 347
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 346
Translational challenges of human herpesvirus 6 chromosomal integration. 345
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 345
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 342
From gating to computational flow cytometry: Exploiting artificial intelligence for MRD diagnostics 341
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 341
Leukaemic pulmonary infiltrates in adult acute myeloid leukaemia: a high-resolution computerized tomography study 341
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 340
3 CASES OF HUMAN HERPESVIRUS-6 LATENT INFECTION - INTEGRATION OF VIRAL GENOME IN PERIPHERAL-BLOOD MONONUCLEAR CELL-DNA 338
An unusual case of splenomegaly and increased lactate dehydrogenase heralding acute myeloid leukemia with eosinophilia and RUNX1-MECOM fusion transcripts 338
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients 335
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 334
Ocular involvement as first sign of isolated CNS relapse in diffuse large B-cell lymphoma 333
Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors 332
Immunophenotypic Profile and Clinical Outcome of Monoclonal B-cell Lymphocytosis in Kidney Transplantation 327
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 326
Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura. 325
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 325
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 324
Cytarabine-related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patients. 324
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 323
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 321
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 321
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 320
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 319
Rhodotorula infection in haematological patient: risk factors and outcome 319
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 318
Dual inhibition of PI3K/mTOR signaling in chemoresistant AMLprimary cells. 316
invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 315
Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy 315
T-cell large granular lymphocyte leukemia in solid organ transplant recipients: case series and review of the literature 315
Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trial 314
Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience 313
Missense mutations in the PML/RAR alpha ligand binding domain in ATRA-resistant As2O3 sensitive relapsed acute promyelocytic leukemia 312
Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: Case report and review of the literature 311
Parvoviruses in blood donors and transplant patients, Italy 311
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 311
Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma 310
Absence of a directly causative role for human herpesvirus 7 in human lymphoma and a review of human herpesvirus 6 in human malignancy 309
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 308
Angiogenesis in multiple myeloma: Correlation between in vitro endothelial colony growth (CFU-En) and clinical biological features 308
A possible role for low-dose cyclosporine in refractory immune thrombocytopenic purpura. 305
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial 305
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 304
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 300
Diagnosis of aspergillosis: Role of proteomics 299
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 298
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 298
Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature. 297
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 296
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections 296
Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet 294
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 293
Clinical differences in sarcoidosis patients with and without lymphoma: a single-center retrospective cohort analysis. 293
Totale 35.567
Categoria #
all - tutte 436.005
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 436.005


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021616 0 0 0 0 0 0 0 0 0 0 0 616
2021/20227.626 429 921 761 423 209 387 457 379 811 560 1.263 1.026
2022/20237.922 981 833 575 700 1.066 1.089 168 789 949 127 338 307
2023/20245.851 204 312 371 497 1.142 482 643 885 124 177 336 678
2024/202518.358 667 248 297 1.282 3.087 2.584 1.353 976 2.315 1.045 2.018 2.486
2025/202637.520 2.595 1.667 3.532 3.952 5.107 2.757 4.475 1.906 3.499 3.208 2.841 1.981
Totale 109.382